HCA Healthcare (NYSE: HCA) insider transactions

In the twelve months to 10 November 2026, executives and directors of HCA Healthcare reported 22 open-market sales of 94,504 shares ($47.5m) and 0 open-market purchases, by 8 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in HCA Healthcare shares reported on Form 4
Date	Insider	Role	Transaction	Shares	Price	Held after	Filing
10 November 2026	Rossitto Erica	SVP & Chief Nurse Executive	Open-market sale	−3,500	$505.81	13,426	Form 4
6 November 2026	Rossitto Erica	SVP & Chief Nurse Executive	Option exercise	+8,080	$81.96	18,487	Form 4
6 November 2026	Rossitto Erica	SVP & Chief Nurse Executive	Option exercise	+5,040	$101.16	23,527	Form 4
6 November 2026	Rossitto Erica	SVP & Chief Nurse Executive	Shares withheld for tax	−6,601	$494.99	16,926	Form 4
6 November 2026	Foster Jon M	EVP and COO	Open-market sale	−1,484	$491.98	10,000	Form 4
6 November 2026	Foster Jon M	EVP and COO	Open-market sale	−890	$498.97	30,823	Form 4
6 November 2026	Foster Jon M	EVP and COO	Open-market sale	−1,684	$498.00	29,139	Form 4
6 November 2026	Foster Jon M	EVP and COO	Open-market sale	−1,066	$496.92	28,073	Form 4
6 November 2026	Foster Jon M	EVP and COO	Open-market sale	−2,692	$495.85	25,381	Form 4
6 November 2026	Foster Jon M	EVP and COO	Open-market sale	−7,595	$494.91	17,786	Form 4
6 November 2026	Foster Jon M	EVP and COO	Open-market sale	−6,302	$493.58	11,484	Form 4
4 November 2026	Frist Thomas F Iii	Director	Other	−555,500	$503.53	32,282,889	Form 4
4 November 2026	Frist Thomas F Iii	Director	Other	+555,500	$503.53	32,282,889	Form 4
4 November 2026	Elcan Patricia F	—	Other	−886,871	$503.53	32,282,889	Form 4
4 November 2026	Elcan Patricia F	—	Other	+886,871	$503.53	32,282,889	Form 4
4 November 2026	Foster Jon M	EVP and COO	Open-market sale	−10,000	$514.07	0	Form 4
4 November 2026	Foster Jon M	EVP and COO	Option exercise	+35,880	$145.24	35,880	Form 4
4 November 2026	Foster Jon M	EVP and COO	Shares withheld for tax	−20,309	$510.70	15,571	Form 4
4 November 2026	Foster Jon M	EVP and COO	Other	−16,142	$503.53	51,453	Form 4
4 November 2026	Schlosser Michael J	EVP and Chief Clinical Officer	Open-market sale	−1,200	$494.65	1,443	Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the HCA Healthcare page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.